Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 11:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 577–600 of 1,807 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Implanted Device Clear all

Conditions: Glaucoma
Interventions: Ahmed implant, Baerveldt implant; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 85 Years
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2014
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Urinary Incontinence, Urinary Incontinence (UI), Urinary Incontinence , Stress, Urinary Incontinence Due to Urethral Sphincter Incompetence, Urethral Sphincter Activity, Intrinsic Sphincter Deficiency, Pelvic Floor Dysfunction
Interventions: NASHA Dx, Bulkamid; Device
Lead sponsor: Palette Life Sciences, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Tustin, California • Lincoln, Nebraska • Charlotte, North Carolina + 2 more

Conditions: Parkinson's Disease
Interventions: Activa PC+S; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 45 Years to 75 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Spinal Cord Injury, ALS (Amyotrophic Lateral Sclerosis)
Interventions: Eye Tracker, Mouth Operated Joystick, Non-invasive electroencephalogram (EEG) Headset, Implantable Brain-Computer-Interface, Personal Assistive Technology, Voice Control; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Heart Failure, Systolic
Interventions: Yoga training; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS)
Interventions: Zenflow Spring System, Sham Procedure; Device
Lead sponsor: Zenflow, Inc.; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 7
States / cities: Los Angeles, California • Glenview, Illinois • Las Vegas, Nevada + 3 more

Conditions: Sacroiliac Joint Pain
Interventions: Bone Allograft, Conventional Medical Management (CMM); Procedure · Other
Lead sponsor: PainTEQ, LLC; Industry
Eligibility: 21 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Shenandoah, Texas

Conditions: Glioblastoma
Interventions: IGV-001 Cell Immunotherapy, Placebo, Standard of Care (SOC): Radiation Therapy, SOC: Temozolomide; Combination Product · Procedure · Drug
Lead sponsor: Imvax; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 23
States / cities: Jacksonville, Florida • Boston, Massachusetts • Detroit, Michigan + 15 more

Conditions: Headache Migraine Chronic
Interventions: Neurostimulator; Device
Lead sponsor: ShiraTronics; Industry
Eligibility: 22 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 20
States / cities: Scottsdale, Arizona • Little Rock, Arkansas • La Jolla, California + 16 more

Conditions: Spinal Cord Injuries, Paraplegia, Tetraplegia, Paralysis
Interventions: Percutaneous epidural and dorsal root stimulation; Device
Lead sponsor: Peter J. Grahn, Ph.D.; Other
Eligibility: 22 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: DiGeorge Syndrome, Complete Typical DiGeorge Anomaly
Interventions: Cultured Thymus Tissue for Implantation (CTTI); Biological
Lead sponsor: Sumitomo Pharma Switzerland GmbH; Industry
Eligibility: Not listed
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Valve Heart Disease
Interventions: blood draw; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 99 Years
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Phoenix, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Knee Prosthesis
Interventions: Stryker posterior cruciat retaining (PCR) total knee arthroplasty (TKA), Zimmer PCR TKA; Device
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 40 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 4
States / cities: Knoxville, Tennessee

Conditions: Ultrasound Therapy; Complications, Cardiac Device Implant, Venous Access
Interventions: Ultrasound guided venous access, Conventional technique; Procedure
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Hip Injuries
Interventions: Fluoroscopy surveillance of patients while walking; Radiation
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 40 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Towson, Maryland • Renton, Washington

Conditions: MacTel (Macular Telangiectasia) Type 2
Interventions: Ciliary neurotrophic factor (CNTF), Surgery; Biological · Procedure
Lead sponsor: Neurotech Pharmaceuticals; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 8
States / cities: Los Angeles, California • Miami, Florida • Atlanta, Georgia + 5 more

Conditions: Biventricular Failure
Interventions: CardioWest temporary Total Artificial Heart (TAH-t) System; Device
Lead sponsor: SynCardia Systems. LLC; Industry
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Phoenix, Arizona • Philadelphia, Pennsylvania • Richmond, Virginia

Conditions: Cardiomyopathy, Coronary Artery Disease, Congestive Heart Failure, Myocardial Infarction
Interventions: Implantable Cardioverter Defibrillator, Optimal Medical Therapy; Device · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 70 Years and older
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Gainesville, Florida • Minneapolis, Minnesota + 2 more

Conditions: Adolescent Idiopathic Scoliosis
Interventions: Pedicle screws, Laminar Hooks; Device
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 7 Years to 21 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Sanfilippo Syndrome
Interventions: Recombinant human heparan N-sulfatase [rhHNS]; Drug
Lead sponsor: Shire; Industry
Eligibility: 12 Months to 48 Months
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: Torrance, California • Minneapolis, Minnesota • Chapel Hill, North Carolina

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Interventions: Continuous Glucose Monitoring System; Device
Lead sponsor: Senseonics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 8
States / cities: Concord, California • Escondido, California • Walnut Creek, California + 5 more

Conditions: Breast Cancer
Interventions: NACgraft; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Glaucoma
Interventions: Brown Glaucoma Implant; Device
Lead sponsor: MicroOptx; Industry
Eligibility: 22 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 3
States / cities: Bloomington, Minnesota • Dayton, Ohio • Dallas, Texas

Conditions: Vocal Fold Palsy, Vocal Cord Paralysis, Vocal Cord Atrophy
Interventions: Silk Voice; Device
Lead sponsor: Sofregen Medical, Inc.; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Ahmed Versus Baerveldt Comparison Study

Trial of NASHA Dx Urethral Bulking System

State-dependent Pathophysiological Oscillations in Parkinson's Disease and Treatment With Deep Brain Stimulation (DBS)

Clinical Outcome Assessment for AT & BCI

The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG

Safety and Effectiveness Study of the Zenflow Spring System

LINQ® Procedure vs. Conventional Medical Management for Sacroiliac Dysfunction

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM

Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury

Thymus Transplantation in DiGeorge Syndrome #668

Identification of Non-gal, Non-HLA Antigens in Patients Implanted With Xenogenic Material

In Vivo Kinematics Comparison of Stryker or Zimmer Total Knee Arthroplasty

Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation

THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches

Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)

SynCardia Freedom Driver System Study

Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly

Pedicle Screw Usage in Conventional Fixation Pattern Constructs Compared to Thoracic Hook Constructs in Scoliosis

Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease

PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days

Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

Early Feasibility Study of the Brown Glaucoma Implant in Patients With Severe Visual Impairment or No Light Perceived

A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid